Moving Beyond Auditory Speech: Improving Equity for Patients and Providers with Diverse Communication Needs
Despite the prevalence of hearing loss or deafness, many physicians are unfamiliar with how best to support patients and colleagues with diverse communication needs.
Category
  • General RO
  • Health Policy/Informatics
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $49.00
Exercise after a Cancer Diagnosis: From Research to Real Life
Exercise has been shown to improve numerous physical, psychosocial and clinical outcomes in those diagnosed with cancer.
Category
  • Patient Safety
  • Professional Development
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Moving Beyond the Basics: Implementation of a Radiopharmaceutical Therapy Program - RPT Workshop 2025
Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 4.50 AMA PRA Category 1 Credit™
  • 4.50 Certificate of Attendance
Cost $379.00
Integration of Radiotherapy with New Systemic Treatments for Breast Cancer
There is a significant gap in the knowledge and practice of integrating novel systemic therapies with radiotherapy in breast cancer management, particularly due to limited clinical trial data on their combined use.
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Molecular Intelligence in Breast Cancer Radiation Therapy
Molecular testing is an integral component of multidisciplinary management of breast cancer. Recent evidence underscores the importance of molecular assays in radiation therapy decision making.
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Advanced Treatment Techniques of Stereotactic, Adaptive and Protons for Gynecologic Cancer – Tips, Tricks and Patient Selection
This activity discusses some of the newer treatment techniques, including stereotactic body radiation (SBRT), adaptive radiation therapy and protons being utilized in gynecologic cancer.
Category
  • Adaptive RT
  • Gynecologic
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Leveraging Anti-Tumor Immunity with Radiopharmaceutical Therapy (RPT) and Potential Combinatorial Approaches with RPT and Immunotherapy
Radiopharmaceutical Therapy (RPT) is an emerging modality with significant potential to impact future oncological management across many disease settings.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Optimizing Sequencing in Immunotherapy and Radiotherapy for Non-Small Cell Lung Cancer – Clinical and Translational Advances
This combined immunotherapy track and lung cancer track brings together leading experts to discuss recent, cutting-edge trials and strategies in treating both locally advanced and metastatic non-small cell lung cancer (NSCLC). Dr.
Category
  • Immunotherapy
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Multidisciplinary Lung Cancer Tumor Board: A Case-Based Discussion Spanning Bread-and-Butter through the Gray Zone
The management of locally advanced lung cancer increasingly relies on multidisciplinary collaboration. Advances in neoadjuvant and perioperative chemoimmunotherapy have significantly improved outcomes for patients with resectable non-small cell lung cancer.
Category
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Neoadjuvant Immunotherapy in Head and Neck Cancer, Sarcoma and Cutaneous Malignancies
Recent landmark studies in melanoma, cutaneous squamous cell carcinoma (cSCC), head and neck cancer (HNC) and sarcoma have established neoadjuvant immune therapy as a potential standard of care for patients with locally advanced cancers.
Category
  • Head and Neck
  • Immunotherapy
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages